80_FR_71045 80 FR 70825 - Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee

80 FR 70825 - Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 220 (November 16, 2015)

Page Range70825-70826
FR Document2015-28847

The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Tobacco Products Scientific Advisory Committee, Office of Science, Center for Tobacco Products. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups.

Federal Register, Volume 80 Issue 220 (Monday, November 16, 2015) 
[Federal Register Volume 80, Number 220 (Monday, November 16, 2015)]
[Notices]
[Pages 70825-70826]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-28847]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0394]


Request for Nominations for Voting Members on a Public Advisory 
Committee; Tobacco Products Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on the Tobacco Products 
Scientific Advisory Committee, Office of Science, Center for Tobacco 
Products.
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore encourages nominations of 
appropriately qualified candidates from these groups.

DATES: Nominations received on or before January 15, 2016 will be given 
first consideration for membership on the Tobacco Products Scientific 
Advisory Committee. Nominations received after January 15, 2016 will be 
considered for nomination to the committee as later vacancies occur.

ADDRESSES: All nominations for membership should be sent electronically 
by logging into the FDA Advisory Committee Membership Nomination 
Portal: http://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and Management 
Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, Rm. 5103, Silver Spring, MD 20993-0002.

FOR FURTHER INFORMATION CONTACT:  Regarding all nomination questions 
for membership, the primary contact is:
    Caryn Cohen, Office of Science, Center for Tobacco Products, Food 
and Drug Administration, Center for Tobacco Products, Document Control 
Center, Building 71, Rm. G335, 10903 New Hampshire Ave., Silver Spring, 
MD 20993-0002, 1-877-287-1373 (choose Option 5), FAX: 240-276-3655, 
TPSAC@fda.hhs.gov.
    Information about becoming a member on an FDA advisory committee 
can also be obtained by visiting FDA's Web site by using the following 
link: http://www.fda.gov/AdvisoryCommittees/default.htm.

SUPPLEMENTARY INFORMATION:  FDA is requesting nominations for voting 
members on the Tobacco Products Scientific Advisory Committee.

I. General Description of the Committee Duties

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner of Food and Drugs (the Commissioner) or 
designee in discharging responsibilities related to the regulation of 
tobacco products. The Committee reviews and evaluates safety, 
dependence, and health issues relating to tobacco products and provides 
appropriate advice, information, and recommendations to the 
Commissioner.

II. Criteria for Voting Members

    The Committee consists of 12 members including the Chair. Members 
and the Chair are selected by the Commissioner or designee from among 
individuals knowledgeable in the fields of medicine, medical ethics, 
science, or technology involving the manufacture, evaluation, or use of 
tobacco products. Almost all non-Federal members of this committee 
serve as Special Government Employees. Members will be invited to serve 
for terms of up to 4 years. The Committee includes nine technically 
qualified voting members, selected by the Commissioner or designee. The 
nine voting members include seven members who are physicians, dentists, 
scientists, or health care professionals practicing in the area of 
oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, 
or any other relevant specialty. The nine voting members also include 
one member who is an officer or employee of a state or local government 
or of the Federal Government, and one member who is a representative of 
the general public.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the advisory committee. Self-nominations 
are also accepted. Nominations must include a current, complete 
r[eacute]sum[eacute] or curriculum vitae for each nominee, including 
current business address and/or home address, telephone number, and 
email address if available. Nominations must also

[[Page 70826]]

specify the advisory committee for which the nominee is recommended. 
Nominations must also acknowledge that the nominee is aware of the 
nomination unless self-nominated. FDA will ask potential candidates to 
provide detailed information concerning such matters related to 
financial holdings, employment, and research grants and/or contracts to 
permit evaluation of possible sources of conflicts of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: November 9, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-28847 Filed 11-13-15; 8:45 am]
BILLING CODE 4164-01-P

Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices 70825 discontinued product(s), including the 1–800–741–8138 (301–443–0572 in the New Hampshire Ave., Silver Spring, MD product NDC number(s), and stating that Washington DC area), and follow the 20993–0002, 1–877–287–1373 (choose the manufacturing and/or distribution of prompts to the desired center or product Option 5), FAX: 240–276–3655, the product(s) have been discontinued. area. Please call the Information Line for TPSAC@fda.hhs.gov. The letter should be sent electronically up-to-date information on this meeting. Information about becoming a to Barbara Wise (see FOR FURTHER Dated: November 9, 2015. member on an FDA advisory committee INFORMATION CONTACT). FDA plans to can also be obtained by visiting FDA’s Leslie Kux, rely on its existing records, including its Web site by using the following link: Associate Commissioner for Policy. http://www.fda.gov/ drug listing records, the results of any [FR Doc. 2015–28846 Filed 11–13–15; 8:45 am] AdvisoryCommittees/default.htm. future inspections, or other available information, when it targets violative BILLING CODE 4164–01–P SUPPLEMENTARY INFORMATION: FDA is products for enforcement action. requesting nominations for voting members on the Tobacco Products IV. Reformulated Products DEPARTMENT OF HEALTH AND Scientific Advisory Committee. FDA cautions firms against HUMAN SERVICES I. General Description of the Committee reformulating products into unapproved Food and Drug Administration Duties new drugs and marketing under the same name or substantially the same [Docket No. FDA–2009–N–0394] The Tobacco Products Scientific name (including a new name that Advisory Committee (the Committee) contains the old name). Reformulated Request for Nominations for Voting advises the Commissioner of Food and products marketed under a name Members on a Public Advisory Drugs (the Commissioner) or designee in previously identified with a different Committee; Tobacco Products discharging responsibilities related to active ingredient or combinations of Scientific Advisory Committee the regulation of tobacco products. The active ingredients have the potential to AGENCY: Food and Drug Administration, Committee reviews and evaluates safety, confuse health care practitioners and HHS. dependence, and health issues relating harm patients. to tobacco products and provides ACTION: Notice. appropriate advice, information, and Dated: November 9, 2015. SUMMARY: The Food and Drug recommendations to the Commissioner. Leslie Kux, Administration (FDA) is requesting II. Criteria for Voting Members Associate Commissioner for Policy. nominations for voting members to [FR Doc. 2015–28853 Filed 11–13–15; 8:45 am] The Committee consists of 12 serve on the Tobacco Products Scientific BILLING CODE 4164–01–P members including the Chair. Members Advisory Committee, Office of Science, and the Chair are selected by the Center for Tobacco Products. FDA seeks to include the views of Commissioner or designee from among DEPARTMENT OF HEALTH AND women and men, members of all racial individuals knowledgeable in the fields HUMAN SERVICES and ethnic groups, and individuals with of medicine, medical ethics, science, or and without disabilities on its advisory technology involving the manufacture, Food and Drug Administration evaluation, or use of tobacco products. committees and, therefore encourages [Docket No. FDA–2015–N–0001] nominations of appropriately qualified Almost all non-Federal members of this candidates from these groups. committee serve as Special Government Gastroenterology and Urology Devices Employees. Members will be invited to DATES: Nominations received on or Panel of the Medical Devices Advisory serve for terms of up to 4 years. The before January 15, 2016 will be given Committee includes nine technically Committee; Amendment of Notice first consideration for membership on qualified voting members, selected by AGENCY: Food and Drug Administration, the Tobacco Products Scientific the Commissioner or designee. The nine HHS. Advisory Committee. Nominations voting members include seven members ACTION: Notice. received after January 15, 2016 will be who are physicians, dentists, scientists, considered for nomination to the or health care professionals practicing SUMMARY: The Food and Drug committee as later vacancies occur. in the area of oncology, pulmonology, Administration (FDA) is canceling the ADDRESSES: All nominations for cardiology, toxicology, pharmacology, November 18, 2015, session and membership should be sent addiction, or any other relevant postponing the November 19, 2015, electronically by logging into the FDA specialty. The nine voting members also session of the Gastroenterology and Advisory Committee Membership include one member who is an officer Urology Devices Panel meeting. The Nomination Portal: http:// or employee of a state or local meeting was announced in the Federal www.accessdata.fda.gov/scripts/ government or of the Federal Register of October 7, 2015 (80 FR FACTRSPortal/FACTRS/index.cfm or by Government, and one member who is a 60686). The November 19, 2015, session mail to Advisory Committee Oversight representative of the general public. has been postponed due to the and Management Staff, Food and Drug cancellation of the November 18, 2015, Administration, 10903 New Hampshire III. Nomination Procedures meeting. Future meeting dates will be Ave., Bldg. 32, Rm. 5103, Silver Spring, Any interested person may nominate announced in the Federal Register. MD 20993–0002. one or more qualified individuals for FOR FURTHER INFORMATION CONTACT: FOR FURTHER INFORMATION CONTACT: membership on the advisory committee. tkelley on DSK3SPTVN1PROD with NOTICES Patricio Garcia, Center for Devices and Regarding all nomination questions for Self-nominations are also accepted. Radiological Health, Food and Drug membership, the primary contact is: Nominations must include a current, Administration, 10903 New Hampshire Caryn Cohen, Office of Science, complete résumé or curriculum vitae for Ave., Bldg. 66, Rm. 1535, Silver Spring Center for Tobacco Products, Food and each nominee, including current MD 20993–0002, patricio.garcia@ Drug Administration, Center for business address and/or home address, fda.hhs.gov, 301–796–6875, or FDA Tobacco Products, Document Control telephone number, and email address if Advisory Committee Information Line, Center, Building 71, Rm. G335, 10903 available. Nominations must also VerDate Sep<11>2014 19:47 Nov 13, 2015 Jkt 238001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1

70826 Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices specify the advisory committee for the public during the review and notify the scholar or S2S participant, which the nominee is recommended. approval period. and the NHSC logistics contractor Nominations must also acknowledge DATES: Comments on this ICR should be regarding travel arrangements and that the nominee is aware of the received no later than December 16, authorization of the funding for the site nomination unless self-nominated. FDA 2015. visit or relocation. will ask potential candidates to provide Need and Proposed Use of the ADDRESSES: Submit your comments, detailed information concerning such Information: This information will including the Information Collection matters related to financial holdings, facilitate NHSC scholar and S2S Request Title, to the desk officer for employment, and research grants and/or clinicians’ receipt of federal travel funds HRSA, either by email to OIRA_ contracts to permit evaluation of that are used to visit high-need NHSC submission@omb.eop.gov or by fax to possible sources of conflicts of interest. sites. The Travel Request Worksheet is 202–395–5806. This notice is issued under the also used to initiate the relocation Federal Advisory Committee Act (5 FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests process after an NHSC scholar or S2S U.S.C. app. 2) and 21 CFR part 14, participant has successfully been relating to advisory committees. submitted to OMB for review, email the HRSA Information Collection Clearance matched to an approved practice site. Dated: November 9, 2015. Officer at paperwork@hrsa.gov or call This information will be used by the Leslie Kux, (301) 443–1984. NHSC in order to make travel Associate Commissioner for Policy. arrangements for NHSC scholar and S2S SUPPLEMENTARY INFORMATION: clinicians to potential practice sites and [FR Doc. 2015–28847 Filed 11–13–15; 8:45 am] Information Collection Request Title: to assist them in relocation BILLING CODE 4164–01–P National Health Service Corps Scholar/ arrangements once clinicians have Students to Service Travel Worksheet. secured employment at one of these OMB No. 0915–0278—Extension. DEPARTMENT OF HEALTH AND Abstract: Clinicians participating in sites. HUMAN SERVICES the HRSA National Health Service Likely Respondents: Clinicians Corps (NHSC) Scholarship Program and participating in the National Health Health Resources and Services the Students to Service (S2S) Loan Service Corps Scholarship Program and Administration Repayment Program use the online the Students to Service Loan Repayment Travel Request Worksheet to receive Program Agency Information Collection Statement: Burden in this context travel funds from the federal Activities: Submission to OMB for means the time expended by persons to government to visit eligible NHSC sites Review and Approval; Public Comment generate, maintain, retain, disclose or to which they may be assigned in Request provide the information requested. This accordance with the Public Health AGENCY: Health Resources and Services Service Act (PHSA), section 331(c)(1). includes the time needed to review Administration, HHS. The travel approval process is instructions; to develop, acquire, install ACTION: Notice. initiated when an NHSC scholar or S2S and utilize technology and systems for participant notifies the NHSC of an the purpose of collecting, validating and SUMMARY: In compliance with Section impending interview at one or more verifying information, processing and 3507(a)(1)(D) of the Paperwork NHSC-approved practice sites. The maintaining information, and disclosing Reduction Act of 1995, the Health Travel Request Worksheet is also used and providing information; to train Resources and Services Administration to initiate the relocation process after an personnel and to be able to respond to (HRSA) has submitted an Information NHSC scholar or S2S participant has a collection of information; to search Collection Request (ICR) to the Office of successfully been matched to an data sources; to complete and review Management and Budget (OMB) for approved practice site in accordance the collection of information; and to review and approval. Comments with the PHSA, section 331(c)(3). Upon transmit or otherwise disclose the submitted during the first public review receipt of the Travel Request Worksheet, information. The total annual burden of this ICR will be provided to OMB. the NHSC will review and approve or hours estimated for this ICR are OMB will accept further comments from disapprove the request and promptly summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN-HOURS Average Number of Number of Total burden per Total burden Form name responses per respondents responses response hours respondent (in hours) Travel Request Worksheet .................................................. 250 2 500 .0667 33 Total ..................................................................................... 250 2 500 .0667 33 Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015–29140 Filed 11–13–15; 8:45 am] tkelley on DSK3SPTVN1PROD with NOTICES BILLING CODE 4165–15–P VerDate Sep<11>2014 19:47 Nov 13, 2015 Jkt 238001 PO 00000 Frm 00080 Fmt 4703 Sfmt 9990 E:\FR\FM\16NON1.SGM 16NON1


Document Created: 2015-12-14 14:13:24
Document Modified: 2015-12-14 14:13:24
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesNominations received on or before January 15, 2016 will be given first consideration for membership on the Tobacco Products Scientific Advisory Committee. Nominations received after January 15, 2016 will be considered for nomination to the committee as later vacancies occur.
ContactRegarding all nomination questions for membership, the primary contact is:
FR Citation80 FR 70825 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR